💊 Heparin (Heparin Sodium)
Heparin sodium is an anticoagulant given by injection into a vein or under the skin (deep subcutaneous, intrafat). It is used to prevent and treat blood clots. Your doctor sets the dose and monitors it with blood clotting tests.
In Arabic: هيبارين الصوديوم✅ What it is used for
- Prophylaxis and treatment of venous thrombosis and pulmonary embolism
- Prevention of postoperative deep venous thrombosis and pulmonary embolism in patients undergoing major abdominothoracic surgery or who are otherwise at risk of thromboembolic disease
- Atrial fibrillation with embolization
- Treatment of acute and chronic consumptive coagulopathies (disseminated intravascular coagulation)
- Prevention of clotting in arterial and cardiac surgery
- Prophylaxis and treatment of peripheral arterial embolism
- Anticoagulant use in blood transfusions, extracorporeal circulation, and dialysis procedures
🧪 Active ingredient
The active ingredient is heparin sodium (derived from porcine intestinal mucosa). It binds to the plasma protein antithrombin III and markedly enhances its activity, inhibiting activated clotting factors, particularly Xa and IIa, and preventing formation of a stable fibrin clot. It does not dissolve existing clots.
🌿 Benefits
- Helps prevent blood clots from forming and from growing larger
- Onset of action is immediate after intravenous injection
- Suitable for use during surgery, dialysis, and blood transfusion
📝 How to use
- It is given by injection into a vein (intermittent injection or continuous infusion) or by deep subcutaneous (intrafat) injection, using a different site for each injection
- The intramuscular route should be avoided because of the frequent occurrence of hematoma at the injection site
- The dose is set by your doctor or pharmacist based on blood clotting test results; do not adjust it or use it without medical supervision
- Platelet counts, hematocrit, and occult blood in stool are monitored periodically throughout treatment
💊 Dosage forms
- Preservative-free single-dose vials (e.g., 2,000 units/2 mL and 5,000 units/0.5 mL)
- Multiple-dose vials containing benzyl alcohol
- Multiple-dose vials containing parabens in several strengths (e.g., 1,000, 5,000, 10,000, and 20,000 units/mL)
⚠️ Common side effects
- Bleeding (the chief complication of therapy)
- Low platelet count (thrombocytopenia)
- Injection site irritation: redness, mild pain, hematoma, or ulceration
- Elevated liver enzymes (aminotransferases)
- General hypersensitivity reactions such as chills, fever, and hives
🚨 Serious — seek medical help
- Severe or fatal bleeding at any site, including adrenal hemorrhage (with acute adrenal insufficiency), ovarian hemorrhage, and retroperitoneal hemorrhage
- Heparin-induced thrombocytopenia and thrombosis (HIT/HITTS), including delayed-onset cases
- Anaphylactoid reactions, including shock
- Skin necrosis at subcutaneous injection sites, occasionally requiring skin grafting
- Priapism; osteoporosis with long-term high-dose use
- In neonates and infants: gasping syndrome and other serious reactions from benzyl alcohol in formulations that contain it
⛔ Do not use if
- History of heparin-induced thrombocytopenia or HIT with thrombosis (HIT/HITTS)
- Known hypersensitivity to heparin or pork products
- Patients in whom suitable blood coagulation tests cannot be performed at appropriate intervals (applies to full-dose heparin)
- Uncontrolled active bleeding, except when due to disseminated intravascular coagulation
❗ Warnings & precautions
- Fatal medication errors: do not use heparin sodium injection as a catheter lock flush; fatal hemorrhages have occurred in pediatric patients when vials were confused, so confirm the correct strength before administration
- Hemorrhage: use caution in conditions with increased bleeding risk (e.g., subacute bacterial endocarditis, severe hypertension); an unexplained fall in hematocrit or blood pressure should prompt consideration of hemorrhage
- Higher bleeding incidence has been reported in patients over 60 years of age, particularly women
- Monitor platelet counts and discontinue if signs of HIT/HITTS appear
- Formulations containing benzyl alcohol should not be used in neonates and infants; use the preservative-free formulation
- Inspect the solution before use and do not use if discolored or if a precipitate is present
🔄 Drug interactions
- Oral anticoagulants (warfarin, dicumarol): heparin may prolong the prothrombin time; allow at least 5 hours after the last intravenous dose or 24 hours after the last subcutaneous dose before drawing blood for a valid prothrombin time
- Platelet inhibitors and NSAIDs (salicylic acid, ibuprofen, indomethacin, celecoxib), dextran, phenylbutazone, thienopyridines, dipyridamole, hydroxychloroquine, glycoprotein IIb/IIIa antagonists: may induce bleeding; reducing the dose of the antiplatelet agent or heparin is recommended
- Digitalis, tetracyclines, nicotine, or antihistamines: may partially counteract the anticoagulant action of heparin
- Intravenous nitroglycerin: may decrease partial thromboplastin time with rebound on discontinuation; careful monitoring and dose adjustment recommended
- Antithrombin III (human): enhances the anticoagulant effect of heparin; a reduced heparin dose is recommended to lower bleeding risk
🤰 Pregnancy
There are no adequate data in pregnant women to assess the risk of major birth defects or miscarriage. Published reports did not show increased risk of adverse maternal or fetal outcomes in humans, while early embryo-fetal death was observed in animal studies at doses about 10 times the maximum recommended human dose. The doctor weighs benefits against risks, and preservative-free heparin is recommended during pregnancy when available.
🍼 Breastfeeding
The preservative-free formulation is recommended during lactation. The doctor decides whether the drug is appropriate for a breastfeeding mother.
🧒 Children
There are no adequate and well-controlled studies in pediatric patients; dosing recommendations are based on clinical experience. Pediatric patients, including neonates, have died after heparin vials were confused with catheter lock flush vials. Preservative-free heparin should be used in neonates and infants to avoid benzyl alcohol toxicity.
👴 Older adults
A higher incidence of bleeding has been reported in patients over 60 years of age, particularly women, and they may require lower doses. Plasma heparin levels and aPTT may be higher in these patients.
🌡️ Storage
Store at 20° to 25°C (68° to 77°F), controlled room temperature. Do not use if the solution is discolored, contains a precipitate, or the seal is not intact.
⏰ Missed dose
This drug is usually given in hospital or under medical supervision. If a dose is missed or delayed, inform your doctor or nurse right away; do not double the dose on your own.
🆘 Overdose
Bleeding is the chief sign of heparin overdose. When bleeding requires reversal of the heparin effect, the doctor may use protamine sulfate (1% solution) by very slow infusion, no more than 50 mg in any 10-minute period; each mg neutralizes approximately 100 units of heparin. Protamine can cause fatal reactions resembling anaphylaxis, so it is given only where resuscitation facilities are available. This is an emergency requiring immediate medical care.
💰 Price & brands in your area
🏛️ Official price in Palestine — Ministry of Health price list:
| Product | Company | Pack | Price |
|---|---|---|---|
| Heparin sod> tv heparin sodium | Teva | 5 vial | 115 ₪ |
| HEPARIN INJECTION BP 5000 UNITS/M 5ML 25VIAL HEPARIN SODIUM | True med | 25 Vial | 625 ₪ |
📍 Find the nearest pharmacy
Your location is used only in your browser to show nearby pharmacies — we don't store it.
Open in Google Maps👨⚕️ For healthcare professionals
Mechanism of action
Heparin binds antithrombin III, inducing a conformational change that markedly enhances its serine protease activity, thereby inhibiting activated clotting factors, particularly Xa and IIa (small amounts inhibit Xa, larger amounts inhibit thrombin). It also prevents formation of a stable fibrin clot by inhibiting activation of the fibrin-stabilizing factor, and has no fibrinolytic activity. Pharmacokinetics: not absorbed orally; immediate onset after IV administration; volume of distribution 0.07 L/kg; highly bound to antithrombin, fibrinogens, globulins, serum proteases, and lipoproteins; no enzymatic degradation; cleared by liver and reticuloendothelial uptake with biphasic clearance (rapid saturable, then slower first-order); dose-dependent half-life of 0.5 to 2 hours.
Labeled dosing
General adult dosing per label (based on a 68 kg patient; adjust by laboratory monitoring). Deep subcutaneous: initial 5,000 units IV, then 10,000 to 20,000 units of a concentrated solution subcutaneously; then every 8 hours 8,000 to 10,000 units or every 12 hours 15,000 to 20,000 units. Intermittent IV: initial 10,000 units, then 5,000 to 10,000 units every 4 to 6 hours, undiluted or in 50 to 100 mL of 0.9% sodium chloride. Continuous IV infusion: initial 5,000 units IV, then 20,000 to 40,000 units/24 hours in 1,000 mL of 0.9% sodium chloride or a compatible solution. Adjust to aPTT of 1.5 to 2 times normal or whole blood clotting time of about 2.5 to 3 times control. The final dose is determined by the treating physician according to the patient's condition.
- For continuous infusion, invert the container at least six times to ensure adequate mixing and prevent pooling of heparin
- When starting continuous IV infusion, obtain baseline aPTT, INR, and platelet count, then follow aPTT approximately every 4 hours and at appropriate intervals thereafter
- For intermittent IV injection, perform coagulation tests before each injection during initiation and at appropriate intervals thereafter
- After deep subcutaneous injections, tests for dose adequacy are best performed on samples drawn 4 to 6 hours after injection
- Periodically monitor platelet counts, hematocrit, and occult blood in stool regardless of route
- Confirm the correct vial strength and never confuse with catheter lock flush vials
🎓 Key points for students
- Heparin is a heterogeneous group of straight-chain anionic glycosaminoglycans, strongly acidic due to its sulfate and carboxylic acid groups
- Mechanism: potentiates antithrombin III, inhibiting Xa and IIa; low doses inhibit Xa, higher doses inhibit thrombin
- Not absorbed orally so given parenterally; half-life 0.5 to 2 hours and dose-dependent
- Monitoring: aPTT (target 1.5 to 2 times normal) or whole blood clotting time (2.5 to 3 times control)
- Key adverse effects: hemorrhage, HIT/HITTS, skin necrosis, osteoporosis with long-term use
- Antidote: protamine sulfate (1 mg neutralizes about 100 heparin units; max 50 mg per 10 minutes)
- Safety alert: confusion of heparin vials with catheter lock flush vials has caused pediatric deaths
EME runs your whole clinic: appointments with WhatsApp reminders, patient files, finance & inventory, a patient portal and a members-price medical store — with your data isolated and protected.
Try EME free How we protect your data❓ FAQ
What is heparin and what is it used for?
Heparin is an anticoagulant given by injection to prevent and treat blood clots, including venous thrombosis and pulmonary embolism, and for use in certain surgeries, dialysis, and blood transfusions.
Can I use it on my own?
No. The dose is set by your doctor or pharmacist based on blood clotting tests. Do not adjust the dose or use it without medical supervision.
What are the most serious side effects?
The most serious are bleeding and heparin-induced thrombocytopenia with possible clotting. Tell your doctor immediately about unusual bleeding, bruising, or any new symptoms.
Is it safe in pregnancy and breastfeeding?
Published reports did not show increased risk to mother or fetus, but your doctor decides after weighing benefits and risks, and preservative-free heparin is recommended.
Which medicines raise bleeding risk with heparin?
Aspirin and other NSAIDs, platelet inhibitors, warfarin, and others. Tell your doctor about all medicines you take.
⚕️ For education only — not a substitute for advice from your doctor or pharmacist. Do not start or stop any medicine without advice. Source: official FDA drug label via openFDA (2026-04), simplified. Updated: 2026-11-15.